Exact Sciences Corporation (EXAS): Price and Financial Metrics
Exact Sciences Corporation (EXAS)
Today's Latest Price: $59.12 USD
3.24 (5.80%)
Updated Apr 2 10:32am
Add EXAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
EXAS Stock Summary
- Exact Sciences Corp's market capitalization of $8,107,139,709 is ahead of 86.41% of US-listed equities.
- With a price/sales ratio of 9.25, Exact Sciences Corp has a higher such ratio than 91.29% of stocks in our set.
- Revenue growth over the past 12 months for Exact Sciences Corp comes in at 92.82%, a number that bests 93.83% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Exact Sciences Corp are BL, CVLT, IRTC, NVRO, and TDOC.
- Visit EXAS's SEC page to see the company's official filings. To visit the company's web site, go to www.exactsciences.com.
EXAS Daily Price Range
EXAS 52-Week Price Range
EXAS Stock Price Chart More Charts
EXAS Price/Volume Stats
| Current price | $59.12 | 52-week high | $123.99 |
| Prev. close | $55.88 | 52-week low | $35.25 |
| Day low | $55.36 | Volume | 520,747 |
| Day high | $59.74 | Avg. volume | 2,671,017 |
| 50-day MA | $76.31 | Dividend yield | N/A |
| 200-day MA | $94.92 | Market Cap | 8.75B |
Exact Sciences Corporation (EXAS) Company Bio
Exact Sciences is a molecular diagnostics company focused on gastrointestinal cancers. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The company was founded in 1995 and is based in Madison, Wisconsin.
Loading social stream, please wait...